812
Y. Hamashima et al. / Tetrahedron 57 (2001) 805±814
1
the product (1.34 g, 52.4%) as the white powder: H NMR
(CDCl3) d 8.3 (s, 2H), 7.8 (d, J8.25 Hz, 2H), 7.68 (dd,
J8.85, 10.7 Hz, 4H), 7.57 (dd, J8.85, 10.7 Hz, 4H), 7.31
(dt, J0.95, 6.73 Hz, 2H), 7.10 (t, J7.35 Hz, 2H), 6.92 (d,
J8.55 Hz, 2H), 6.70 (dd, J2.1, 8.85 Hz, 4H), 6.64 (dd,
J2.1, 8.85 Hz, 4H), 4.25 (d, J11 Hz, 2H), 4.23 (d,
J11 Hz, 2H), 4.01 (t, J15 Hz, 2H), 3.89 (t, J15 Hz,
2H), 2.96 (s, 24H), 2.78(s, 6H); 13C NMR (CDCl3) d 152.5
(d, J15 Hz), 152 (d, J9.3 Hz), 152 (d, J 9.3 Hz), 133,
132.4 (d, J10 Hz), 132.2 (d, J10 Hz), 131.3, 131.2, 130.6,
130.6, 128, 127 (d, J6.3 Hz), 126 (d, J4.1 Hz), 125.3,
124.7, 111.3 (d, J10 Hz), 111.2 (d, J11 Hz), 40, 40,
31.5 (d, J68 Hz); 31P NMR (CDCl3) d 35.2 ppm.
mixture was allowed to stir for the time shown in Table 1
at the same temperature. 2N HCl (1.0 mL) was added, and
the mixture was stirred vigorously at room temperature for
1 h to hydrolyze the trimethylsilylether of the product. After
the addition of ethyl acetate (3.0 mL), the mixture was
stirred for further 30 min. The organic layer was separated
and washed with water. The aqueous layer was extracted
with ethyl acetate (20 mL£2). The combined organic layer
was washed with brine and dried over Na2SO4. The crude
product was further puri®ed by ¯ash chromatography
(hexane/ethyl acetate10:1) to give
a cyanohydrin
(12a±12j) in more than 86%. The enantiomeric excesses
of the products were determined after the conversion to
acetylester, benzoylester, p-nitrobenzoylester, ethylcarbo-
nate, and t-butyldimethylsilylether by usual methods.
3.2.7. (R)-3,30-Bis(bis(p-N,N-dimethylaminophenyl)phos-
phinoylmethyl)-1,10-binaphthol (6-L). The MOM protected
6-L (1.34 g, 1.38 mmol) was dissolved in the mixture of
methanol/CH2Cl2 (12 mL/12 mL). A catalytic amount of
TsOH (monohydrate) was added and the mixture was stirred
at 408C over night. Most of the solvent was removed and the
residue was diluted with ethyl acetate (10 mL). The solvent
was washed with sat. aq NaHCO3 (10 mL£2) and the
aqueous layer was extracted with ethyl acetate (10 mL£3).
The combined organic layer was washed with brine and dried
over Na2SO4. The crude product was further puri®ed by
recrystallization to give 6-L (0.8 g, 66%): IR (KBr) n 3518,
3.4.1. (2S)-2-Hydroxy-4-phenylbutanenitrile (12a). This
product was found to be identical with the reported
compound by analytical data: [a]24 16.68 (c0.68,
D
CHCl3) (97% ee) [lit.14 [a]24 22.68 (c2.7, CHCl3) for
D
R enantiomer in 40% ee]. The enantiomeric excess was
determined by HPLC after the conversion to TBDMS±
1
ether: IR (neat) n 3086, 3064, 3028, 1255, 1113 cm21; H
NMR (CDCl3) d 7.32±7.29 (m, 2H), 7.24±7.18 (m, 3H),
4.42 (t, J6.4 Hz, 1H), 2.81 (m, 2H), 2.12 (m, 2H), 0.90 (s,
9H), 0.18 (s, 3H), 0.13 (s, 3H); 13C NMR (CDCl3) d 140.0,
128.7, 128.4, 126.4, 119.9, 61.2, 37.9, 25.6, 18.1, 20.51,
25.32; MS m/z 218 (M12tBu); Anal. Calcd for
C16H25ONSi: C, 69.76; H,9.15; N, 5.08. Found: C, 69.66;
H, 8.98; N, 5.04; HPLC (DAICEL CHIRALCEL OD,
hexane/2-propanol 99/1, 1.0 mL/min) tR 8.4 min and
10.7 min.
1597, 1517, 1364, 1117 cm21; H NMR (CDCl3) d 8.9 (s,
1
2H), 7.59 (d, J7.9 Hz, 2H), 7.54 (d, J2.2 Hz, 2H), 7.50
(dd, J8.8, 8.8 Hz, 2H), 7.48 (dd, J8.6, 8.6 Hz, 2H), 7.13
(dt, J0.9, 6.7 Hz, 2H), 7.05 (t, J7.7 Hz, 2H), 6.93 (d,
J8.3 Hz, 2H), 6.6 (d, J8.9 Hz, 8H), 3.91 (dd, J14.7,
14.7 Hz, 2H), 3.70 (dd, J14.4, 14.4 Hz, 2H), 2.90 (s,
12H), 2.9 (s, 12H); 13C NMR (CDCl3) d 152.3, 152.0,
152.0, 111.3, 111.2, 133.4, 132.5, 132.4, 130.9, 130.9,
128.3, 127.5, 125.7, 125.0, 123.3, 123.2, 122.9, 118.2, 39.9,
3.4.2. (2S)-2-Hydroxy-n-octanenitrile (12b). 1H NMR
(CDCl3) 4.48 (t, J6.7 Hz, 1H), 2.31 (bs, 1H), 1.88±1.83
(m, 2H), 1.54±1.47 (m, 2H), 1.39±1.26 (m, 6H), 0.90 (t,
J7.0 Hz, 3H); 13C NMR (CDCl3) 119.5, 61.5, 35.3, 31.5,
35.8 (d, J66.9 Hz); 31P NMR (CDCl3)
d
39.8;
[a]21.1 299.18 (c1.87, CH2Cl2).
D
28.6, 24.4, 22.5, 14.0; [a]21 213.38 (c1.0, CHCl3) (98%
D
ee) [lit.15 [a]26 19.18 (c2.82, CHCl3) for R enantiomer
3.3. General procedure for the preparation of the
catalyst
D
in 66% ee]. The enantiomeric excess was determined by
HPLC after the conversion to benzoylester: IR (neat) n
1
1913, 1731 cm21; H NMR (CDCl3) d 8.06 (m, 2H), 7.63
Into a ¯ame dried ¯ask, an achiral phosphine oxide (15 mg,
68.8 mmol) was added and dried at 658C for 2 h under the
reduced pressure. 0.1 mL of dichloromethane was added,
followed by the addition of diethylaluminium chloride
(18 mL, 17.28 mmol, 0.96 M in hexane) under argon atmos-
phere. After stirring for 10 min, the chiral ligand (13 mg,
18.2 mmol) in dichloromethane (0.35 mL) was added at
room temperature. The resulting mixture was stirred at the
same temperature for 1 h to give a clear solution. This
solution can be used directly as the catalyst in catalytic
asymmetric trimethysilylcyanation reactions.
(m, 1H), 7.48 (m, 2H), 5.59 (t, J6.7 Hz, 1H), 2.05 (m, 2H),
1.62±1.54 (m, 2H), 1.43±1.30 (m, 6H), 0.90 (m, 3H); 13C
NMR (CDCl3) d 164.8, 134.0, 130.0, 128.7, 128.4, 117.0,
61.7, 32.5, 31.5, 28.5, 24.6, 22.5, 14.0; [a]16.3 253.48
D
(c0.48, CHCl3) (97% ee); Anal. Calcd for C15H19O2N:
C, 73.44; H, 7.81; N, 5.71. Found: C, 73.22; H, 7.96; N,
5.64; HPLC (DAICEL CHIRALPAK AS, hexane/2-propa-
nol 99/1, 0.5 mL/min) tR 13.4 min and 14.8 min.
3.4.3. (2S)-2-Hydroxy-3-methylbutanenitrile (12c). This
product was found to be identical with the reported
compound by analytical data: [a]19 215.48 (c2.1,
3.4. General procedure for the catalytic asymmetric
trimethylsilylcyanation reactions of aldehydes
D
CHCl3) (90% ee) [lit.14 [a]24 14.28 (c1.3, CHCl3) for
D
R enantiomer in 34% ee]. The enantiomeric excess was
determined by HPLC after the conversion to benzoylester:
To a stirred solution of the catalyst (0.45 mL, 17.28 mmol,
0.0384 M) was added an aldehyde (0.192 mmol) at 2408C.
After 30 min, TMSCN (46 mL, 0.346 mmol) was slowly
added over 10 h using a syringe pump. (Be careful!
TMSCN should be added dropwise from the top of the
¯ask, where the temperature may be above 158C. Because
the melting point of TMSCN is 11±128C.) The reaction
1
IR (neat) n 2970, 1732, 1258 cm21; H NMR (CDCl3) d
8.08±8.05 (m, 2H), 7.51±7.47 (m, 1H), 7.56±7.61 (m, 2H),
5.45 (d, J5.75 Hz, 1H), 2.32 (dqq, J6.7, 6.7, 5.75 Hz,
1H), 1.21 (d, J6.7 Hz, 3H), 1.18 (d, J6.7 Hz, 3H); 13C
NMR (CDCl3) d 164.8, 134.0, 130.0, 128.7, 128.5, 116.0,
66.8, 31.4, 17.9, 17.5; MS m/z 203 (M1); [a]22 248.48
D